Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors.

Society of Obstetrics and Gynecology of Zhejiang Medical Association, Society of Urology of Zhejiang Medical Association, Committee of Breast Cancer of Zhejiang Anticancer Association, Committee of Clinical Pharmacy on Oncology of Zhejiang Anticancer Association (preparation), Committee of Urology of Zhejiang Society for Mathematical Medicine.

Open source

DOI: 10.3724/zdxbyxb-2022-0284
Published: 2022-12-01
Container: Zhejiang Da Xue Xue Bao Yi Xue Ban
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3724/zdxbyxb-2022-0284,
  title = {Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors.},
  author = {Society of Obstetrics and Gynecology of Zhejiang Medical Association and  Society of Urology of Zhejiang Medical Association and  Committee of Breast Cancer of Zhejiang Anticancer Association and  Committee of Clinical Pharmacy on Oncology of Zhejiang Anticancer Association (preparation) and  Committee of Urology of Zhejiang Society for Mathematical Medicine.},
  year = {2022},
  journal = {Zhejiang Da Xue Xue Bao Yi Xue Ban},
  doi = {10.3724/zdxbyxb-2022-0284},
  url = {https://doi.org/10.3724/zdxbyxb-2022-0284}
}

RIS

TY  - JOUR
TI  - Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors.
AU  - Society of Obstetrics and Gynecology of Zhejiang Medical Association
AU  -  Society of Urology of Zhejiang Medical Association
AU  -  Committee of Breast Cancer of Zhejiang Anticancer Association
AU  -  Committee of Clinical Pharmacy on Oncology of Zhejiang Anticancer Association (preparation)
AU  -  Committee of Urology of Zhejiang Society for Mathematical Medicine.
PY  - 2022
JO  - Zhejiang Da Xue Xue Bao Yi Xue Ban
DO  - 10.3724/zdxbyxb-2022-0284
UR  - https://doi.org/10.3724/zdxbyxb-2022-0284
ER  -

APA

Association, S. O. O. A. G. O. Z. M., Association, S. O. U. O. Z. M., Association, C. O. B. C. O. Z. A., (preparation), C. O. C. P. O. O. O. Z. A. A., & Medicine., C. O. U. O. Z. S. F. M. (2022). Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors.. Zhejiang Da Xue Xue Bao Yi Xue Ban. https://doi.org/10.3724/zdxbyxb-2022-0284

Source records

europe-pmc · retrieved 2026-09-27T16:00:47.094Z